Drug Shortage Report for FRAXIPARINE

Last updated on 2021-04-27 History
Report ID 130817
Drug Identification Number 02450631
Brand name FRAXIPARINE
Common or Proper name Fraxiparine®(nadroparin calcium injection (0.6 mL))
Company Name ASPEN PHARMACARE CANADA INC.
Market Status MARKETED
Active Ingredient(s) NADROPARIN CALCIUM
Strength(s) 9500UNIT
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS
Packaging size 10 PF Syringe
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-12-21
Estimated end date 2021-04-23
Actual end date 2021-04-26
Shortage status Resolved
Updated date 2021-04-27
Company comments
Health Canada comments
Contact Address UNIT 8, 1155 NORTH SERVICE ROAD WEST
OAKVILLE, ONTARIO
CANADA L6M 3E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2021-04-27 English Compare
v8 2021-04-26 French Compare
v7 2021-04-26 English Compare
v6 2021-04-21 French Compare
v5 2021-04-21 English Compare
v4 2021-03-22 French Compare
v3 2021-03-22 English Compare
v2 2021-01-04 French Compare
v1 2021-01-04 English Compare